DZ2547A1 - Formes posologiques de sertraline à libération prolongée. - Google Patents

Formes posologiques de sertraline à libération prolongée.

Info

Publication number
DZ2547A1
DZ2547A1 DZ980157A DZ980157A DZ2547A1 DZ 2547 A1 DZ2547 A1 DZ 2547A1 DZ 980157 A DZ980157 A DZ 980157A DZ 980157 A DZ980157 A DZ 980157A DZ 2547 A1 DZ2547 A1 DZ 2547A1
Authority
DZ
Algeria
Prior art keywords
sertraline
dosage forms
extended release
extended
release
Prior art date
Application number
DZ980157A
Other languages
English (en)
Inventor
William John Curatolo
Hyler Lewis Friedman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2547(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2547A1 publication Critical patent/DZ2547A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DZ980157A 1997-07-01 1998-06-30 Formes posologiques de sertraline à libération prolongée. DZ2547A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
DZ2547A1 true DZ2547A1 (fr) 2003-02-08

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980157A DZ2547A1 (fr) 1997-07-01 1998-06-30 Formes posologiques de sertraline à libération prolongée.

Country Status (41)

Country Link
EP (1) EP1007024B1 (fr)
JP (1) JP3786715B2 (fr)
KR (1) KR100369698B1 (fr)
CN (4) CN1475209A (fr)
AP (1) AP1199A (fr)
AR (1) AR038394A2 (fr)
AT (1) ATE245415T1 (fr)
AU (1) AU727152B2 (fr)
BG (1) BG64742B1 (fr)
BR (1) BR9809895A (fr)
CA (1) CA2290969C (fr)
DE (1) DE69816624T2 (fr)
DK (1) DK1007024T3 (fr)
DZ (1) DZ2547A1 (fr)
EA (1) EA001906B1 (fr)
ES (1) ES2202858T3 (fr)
GT (1) GT199800091A (fr)
HK (1) HK1027982A1 (fr)
HN (1) HN1998000099A (fr)
HR (1) HRP980376B1 (fr)
HU (1) HUP0301787A3 (fr)
ID (1) ID23187A (fr)
IL (2) IL152304A0 (fr)
IS (1) IS5267A (fr)
MA (1) MA24585A1 (fr)
NO (1) NO996519L (fr)
NZ (1) NZ501249A (fr)
OA (1) OA11247A (fr)
PA (1) PA8454201A1 (fr)
PE (1) PE84399A1 (fr)
PL (1) PL337799A1 (fr)
PT (1) PT1007024E (fr)
SI (1) SI1007024T1 (fr)
SK (1) SK173299A3 (fr)
TN (1) TNSN98122A1 (fr)
TR (1) TR199903295T2 (fr)
TW (1) TW575437B (fr)
UA (1) UA63953C2 (fr)
UY (1) UY25068A1 (fr)
WO (1) WO1999001122A1 (fr)
ZA (1) ZA985710B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL205109B1 (pl) 1998-11-02 2010-03-31 Elan Pharma Int Ltd Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
DE60035579T2 (de) * 1999-05-20 2008-04-17 Elan Corp. Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
EE05315B1 (et) 1999-09-03 2010-08-16 Eli Lilly And Company Dapoksetiini v?i selle farmatseutiliselt vastuv?etava soola kasutamine ravimi valmistamiseks, mis on ette n„htud imetajal esineva seksuaalse funktsioonih„ire ravimiseks v?i m?jutamiseks
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
KR20030025903A (ko) * 2000-02-10 2003-03-29 비피에스아이 홀딩스, 인코포레이션. 아크릴 장용 코팅 조성물
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
JP5328071B2 (ja) * 2001-04-10 2013-10-30 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 時限パルス放出組成物
CA2457385A1 (fr) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Preparation enterique de fluoxetine
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (fr) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Dispositif d'administration de médicaments à plusieurs unités pour libération pulsatile ou prolongée
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
EP0357364B1 (fr) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company Procédé pour le filage-éclair de torons de polymères secs à partir de film-fibrilles plexifilamentaires
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
AP1199A (en) 2003-08-28
NO996519L (no) 2000-02-29
BG64742B1 (bg) 2006-02-28
GT199800091A (es) 1999-12-21
IL152304A0 (en) 2003-05-29
ZA985710B (en) 2000-01-10
ID23187A (id) 2000-03-23
DE69816624T2 (de) 2004-02-19
EA199900965A1 (ru) 2000-08-28
BG103916A (en) 2000-07-31
NZ501249A (en) 2001-06-29
NO996519D0 (no) 1999-12-28
HN1998000099A (es) 1998-10-22
KR20010013522A (ko) 2001-02-26
CN1475209A (zh) 2004-02-18
ES2202858T3 (es) 2004-04-01
CA2290969C (fr) 2004-02-17
EA001906B1 (ru) 2001-10-22
AU7545198A (en) 1999-01-25
HRP980376B1 (en) 2002-12-31
TW575437B (en) 2004-02-11
PL337799A1 (en) 2000-09-11
AR038394A2 (es) 2005-01-12
SK173299A3 (en) 2000-11-07
IL133081A (en) 2005-09-25
PE84399A1 (es) 1999-09-11
JP3786715B2 (ja) 2006-06-14
CN1475208A (zh) 2004-02-18
HUP0301787A2 (hu) 2003-11-28
AP9801278A0 (en) 1998-06-30
OA11247A (en) 2002-11-19
HK1027982A1 (en) 2001-02-02
ATE245415T1 (de) 2003-08-15
PA8454201A1 (es) 2000-09-29
IL133081A0 (en) 2001-03-19
HRP980376A2 (en) 1999-04-30
CA2290969A1 (fr) 1999-01-14
PT1007024E (pt) 2003-11-28
UA63953C2 (uk) 2004-02-16
TR199903295T2 (xx) 2000-08-21
TNSN98122A1 (fr) 2005-03-15
HUP0301787A3 (en) 2005-04-28
DK1007024T3 (da) 2003-11-17
DE69816624D1 (de) 2003-08-28
CN1494899A (zh) 2004-05-12
WO1999001122A1 (fr) 1999-01-14
KR100369698B1 (ko) 2003-01-30
CN1151783C (zh) 2004-06-02
JP2000513751A (ja) 2000-10-17
AU727152B2 (en) 2000-12-07
SI1007024T1 (en) 2003-12-31
UY25068A1 (es) 2000-12-29
EP1007024B1 (fr) 2003-07-23
IS5267A (is) 1999-11-23
BR9809895A (pt) 2000-08-01
MA24585A1 (fr) 1998-12-31
CN1261273A (zh) 2000-07-26
EP1007024A1 (fr) 2000-06-14

Similar Documents

Publication Publication Date Title
DZ2685A1 (fr) Formulation pharmaceutique orale à libération prolongée.
DE69908638D1 (de) Lithographische kontaktstrukturen
DE69716721D1 (de) Lithographisches offsetdruckverfahren
EE200100134A (et) Kiiresti vabastav tablett
DE69812475T2 (de) Photoresistzusammensetzung
DZ2547A1 (fr) Formes posologiques de sertraline à libération prolongée.
DE69719062D1 (de) Flachdruck
NO20002126L (no) Formulering med forlenget frigjøring
DE69812137D1 (de) Kohlenstoff-kohlenstofffaserverbundwerkstoffe
DE69809633D1 (de) Photoresistzusammensetzung
DE69923159D1 (de) Festkörperbildmatrix
BR9809626B1 (pt) compostos À base de compostos de polialquil-1-oxa-diazaespirodecano.
DE69811326D1 (de) Chromenverbindungen
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
NO993944D0 (no) Utlösermekanisme
IS5260A (is) Uppleystar sertralín samsetningar
DE69814051D1 (de) Trennmittel
DE69812401D1 (de) Schnellkupplung
BR0117073B1 (pt) estrutura à prova d'água de um freio a tambor.
DE69810616D1 (de) Flachdruck
DE59907066D1 (de) Gummituch
DE19881798D2 (de) Waschtisch
ID21262A (id) Progestagen kristalin
DE69823079D1 (de) Bissanzeiger
ES1038294Y (es) Pinza para estampacion de matriculas.